Zhili Cao

855 total citations
24 papers, 428 citations indexed

About

Zhili Cao is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Zhili Cao has authored 24 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Zhili Cao's work include Mechanical Circulatory Support Devices (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Zhili Cao is often cited by papers focused on Mechanical Circulatory Support Devices (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Zhili Cao collaborates with scholars based in China, Japan and France. Zhili Cao's co-authors include Shanqing Li, Tsuyoshi Itoh, Feng Guo, Huiqin Guo, Huaxia Yang, Naixin Liang, Yasushi Narita, H Ohteki, Kojiro Furukawa and Kozo Naito and has published in prestigious journals such as CHEST Journal, The Annals of Thoracic Surgery and Oncotarget.

In The Last Decade

Zhili Cao

23 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhili Cao China 11 177 157 128 115 84 24 428
Katherine Mattock United Kingdom 9 135 0.8× 65 0.4× 78 0.6× 94 0.8× 145 1.7× 15 530
Changcun Fang China 12 116 0.7× 106 0.7× 115 0.9× 96 0.8× 74 0.9× 21 391
Caroline Hu United States 10 98 0.6× 75 0.5× 47 0.4× 68 0.6× 97 1.2× 19 372
Youyi Lu China 12 192 1.1× 130 0.8× 117 0.9× 29 0.3× 178 2.1× 31 485
Gareth J. Padfield United Kingdom 15 216 1.2× 42 0.3× 70 0.5× 329 2.9× 140 1.7× 29 603
Valentina Galuppo Spain 7 161 0.9× 32 0.2× 120 0.9× 174 1.5× 184 2.2× 9 466
Michael A. Bellio United States 13 254 1.4× 87 0.6× 81 0.6× 48 0.4× 97 1.2× 25 432
Jee Won Park South Korea 13 125 0.7× 76 0.5× 94 0.7× 32 0.3× 165 2.0× 33 478
Sergio Sciacca Italy 12 204 1.2× 197 1.3× 126 1.0× 168 1.5× 214 2.5× 33 623
David Santer Austria 10 57 0.3× 34 0.2× 94 0.7× 149 1.3× 93 1.1× 36 329

Countries citing papers authored by Zhili Cao

Since Specialization
Citations

This map shows the geographic impact of Zhili Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhili Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhili Cao more than expected).

Fields of papers citing papers by Zhili Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhili Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhili Cao. The network helps show where Zhili Cao may publish in the future.

Co-authorship network of co-authors of Zhili Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhili Cao. A scholar is included among the top collaborators of Zhili Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhili Cao. Zhili Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Huaxia, Yadong Wang, Ziqi Jia, et al.. (2021). Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer. Frontiers in Oncology. 11. 537735–537735. 9 indexed citations
3.
Wang, Yadong, Tiange Wang, Ziqi Jia, et al.. (2021). Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report. Frontiers in Pharmacology. 12. 809467–809467. 5 indexed citations
4.
Bing, Zhongxing, Ziqi Jia, Yadong Wang, et al.. (2021). Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report. Thoracic Cancer. 12(14). 2130–2133. 5 indexed citations
5.
Cao, Zhili, et al.. (2020). Efficacy of on-pump coronary artery bypass grafting and stent implantation combined with surgery on lung cancer.. PubMed. 24(6). 2253–2259. 1 indexed citations
6.
Song, Yang, Ziqi Jia, Yadong Wang, et al.. (2020). Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q. Journal of Thoracic Disease. 12(5). 2771–2780. 5 indexed citations
7.
Wang, Yadong, Xiaoying Yang, Xu Tian, et al.. (2020). Neoadjuvant immunotherapy plus chemotherapy achieved pathologic complete response in stage IIIB lung adenocarcinoma harbored EGFR G779F: a case report. Annals of Palliative Medicine. 9(6). 4339–4345. 3 indexed citations
8.
Yang, Huaxia, Zhuoran Yao, Xiaoxiang Zhou, et al.. (2020). Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study. Annals of Translational Medicine. 8(21). 1415–1415. 3 indexed citations
9.
Cao, Zhili, Naixin Liang, Huaxia Yang, & Shanqing Li. (2017). Visfatin mediates doxorubicin resistance in human non–small‐cell lung cancer via Akt‐mediated up‐regulation of ABCC1. Cell Proliferation. 50(5). 24 indexed citations
10.
Yang, Huaxia, Naixin Liang, Min Wang, et al.. (2017). Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus. Oncotarget. 8(44). 77400–77406. 76 indexed citations
11.
Cao, Zhili, et al.. (2013). Translational medicine in China: Awareness is increasing and research is advancing. Science China Life Sciences. 56(9). 861–862. 2 indexed citations
12.
Wang, H., Qiankun Zhu, Ping Ye, et al.. (2012). Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2.. PubMed. 6(6). 325–32. 28 indexed citations
13.
Liu, Hongsheng, Shanqing Li, Zhili Cao, Zhiyong Zhang, & Hua Ren. (2009). Clinical Features and Treatment of Bronchogenic Cyst in Adults. Chinese Medical Sciences Journal. 24(1). 60–63. 24 indexed citations
14.
Cao, Zhili, Xiang Zheng, Mu Wang, et al.. (2009). [Micronucleus rate and chromosome aberration of mouse embryo liver induced by formaldehyde].. PubMed. 38(6). 667–71. 2 indexed citations
15.
Furukawa, Kojiro, H Ohteki, Zhili Cao, et al.. (2004). Evaluation of native valve-sparing aortic root reconstruction with direct imaging— reimplantation or remodeling?. The Annals of Thoracic Surgery. 77(5). 1636–1641. 15 indexed citations
16.
Cao, Zhili, et al.. (2000). Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. The Annals of Thoracic Surgery. 69(4). 1121–1126. 30 indexed citations
17.
Okazaki, Yukio, Zhili Cao, Satoshi Ohtsubo, et al.. (2000). Leukocyte-depleted reperfusion after long cardioplegic arrest attenuates ischemia–reperfusion injury of the coronary endothelium and myocardium in rabbit hearts✩. European Journal of Cardio-Thoracic Surgery. 18(1). 90–97. 10 indexed citations
18.
Furukawa, Kojiro, H Ohteki, Zhili Cao, et al.. (1999). Does dilatation of the sinotubular junction cause aortic regurgitation?. The Annals of Thoracic Surgery. 68(3). 949–953. 69 indexed citations
19.
Cao, Zhili, et al.. (1998). Veno-Right Ventricular Extracorporeal Membrane Oxygenation for Thoracic Surgery. CHEST Journal. 114(1). 229–235. 2 indexed citations
20.
Naito, Kozo, Zhili Cao, Hisao Suda, et al.. (1996). Comparative Hemolysis Study of Clinically Available Centrifugal Pumps. Artificial Organs. 20(5). 560–563. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Mattock Breakdown of academic impact, for papers by Changcun Fang Breakdown of academic impact, for papers by Caroline Hu Breakdown of academic impact, for papers by Youyi Lu Breakdown of academic impact, for papers by Gareth J. Padfield Breakdown of academic impact, for papers by Valentina Galuppo Breakdown of academic impact, for papers by Michael A. Bellio Breakdown of academic impact, for papers by Jee Won Park Breakdown of academic impact, for papers by Sergio Sciacca Breakdown of academic impact, for papers by David Santer
Rankless by CCL
2026